Tech Company Financing Transactions
Exosome Diagnostics Funding Round
Arcus Ventures, Blue Ridge Capital and CD Ventures invested in a $60 million Series B funding round for Exosome Diagnostics. The round closed on 1/7/2016.
Transaction Overview
Company Name
Announced On
1/7/2016
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series B
Investors
Proceeds Purpose
Exosome Diagnostics expects to use the funds to support the growth of its commercial diagnostics, regulatory, and companion diagnostics divisions, as well as the development of potential new diagnostic tests outside of oncology, such as in neurodegenerative diseases, and expand the development of its protein biomarker programs. These divisions and technology differentiators, such as its protein biomarker interrogation capabilities, will further distinguish Exosome Diagnostics as the industry leader in the liquid biopsy space.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
266 Second Ave. 200
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Developing and commercializing personalized biofluid-based diagnostic tests for use in companion diagnostic applications and real-time disease monitoring.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 1/7/2016: Xevo venture capital transaction
Next: 1/7/2016: SiSense venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs